Original Research
Accepted on 30 Jan 2026
Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients
in Thoracic Oncology
Frontiers in Oncology
- 180 views
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,969 articles
articles
Original Research
Accepted on 30 Jan 2026
Composite Patient-Reported Outcomes and Risk Prediction for Overall Survival in Advanced Non-Small Cell Lung Cancer With First-Line Cemiplimab
in Thoracic Oncology
Frontiers in Oncology
- 114 views
Original Research
Accepted on 30 Jan 2026
Cadonilimab (PD-1/CTLA-4 bispecific antibody) combination therapy for Driver Gene-Negative Advanced NSCLC: A Single-Center Retrospective Real-World Study
in Thoracic Oncology
Frontiers in Oncology
- 180 views
Original Research
Accepted on 29 Jan 2026
The STAT3–ZEB1 axis contributes to CCL2-mediated resistance to osimertinib in lung cancer
in Thoracic Oncology
Frontiers in Oncology
Case Report
Published on 29 Jan 2026
Furmonertinib plus pemetrexed in the treatment of EGFR exon 19 deletion lung adenocarcinoma: two case reports
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1709552
- 555 views
Case Report
Published on 29 Jan 2026
Case Report: Complete pathologic response to neoadjuvant immunotherapy-chemotherapy in a patient with RET fusion-positive non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1730615
- 453 views
Mini Review
Published on 29 Jan 2026
The chick embryo chorioallantoic membrane as an experimental model to study lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1758487
- 446 views
Editorial
Accepted on 28 Jan 2026
Editorial: Treatment Response and Resistance to Targeted Therapies for NSCLC
in Thoracic Oncology
Frontiers in Oncology
Systematic Review
Accepted on 28 Jan 2026
ctDNA clearance predicts survival in unresectable EGFR-mutant NSCLC: a meta-analysis
in Thoracic Oncology
Frontiers in Oncology
- 167 views
Original Research
Published on 28 Jan 2026
Shox2 and Rassf1a DNA methylation: diagnostic utility and association with clinical stage, histological progression and gene mutational landscape in lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1727695
- 435 views
Original Research
Published on 27 Jan 2026
Efficacy of TKIs in non-small cell lung cancer with atypical EGFR p.L747P and p.L747S mutations
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1717191
- 646 views
Correction
Published on 27 Jan 2026
Correction: Factors associated with longer brain metastasis-free survival in limited-disease small-cell lung cancer who underwent concurrent chemoradiotherapy, a retrospective analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1791673
- 335 views
Case Report
Published on 27 Jan 2026
Triple-positive non-small cell lung cancer harboring EGFR mutation, ALK rearrangement, and high PD-L1 expression: a case report and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1727899
- 1,027 views
Original Research
Published on 27 Jan 2026
Postoperative pulmonary rehabilitation compliance among patients with lung cancer: a cross-sectional survey
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1687014
- 869 views
Original Research
Published on 27 Jan 2026
Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1651192
- 603 views
Case Report
Accepted on 26 Jan 2026
Case Report: Pembrolizumab Monotherapy Achieves Durable Disease Control in a Patient with BRAF V600E-Mutant Advanced Lung Adenocarcinoma and High PD-L1 Expression Intolerant to BRAF/MEK Inhibition
in Thoracic Oncology
Frontiers in Oncology
- 156 views
Study Protocol
Published on 26 Jan 2026
TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naïve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterations
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1721624
- 1,432 views
Original Research
Published on 26 Jan 2026
CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1661650
- 968 views
Original Research
Published on 23 Jan 2026
Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer combined with moderate-to-severe pulmonary dysfunction
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1750853
- 784 views
Review
Published on 23 Jan 2026
Direct pulmonary delivery route in lung cancer: a highway for siRNA therapeutics
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1722906
- 747 views
Original Research
Published on 23 Jan 2026
Impact of smoking on immune feature and prognosis in unresectable stage III anaplastic lymphoma kinase positive non-small-cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1594479
- 546 views
Original Research
Published on 22 Jan 2026
Translational impact of machine learning-driven predictive modeling with pathway-based plasma metabolomic biomarkers for lung cancer detection
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1718863
- 674 views
Review
Published on 22 Jan 2026
Brain metastases from non-small cell lung cancer: molecular subtypes and emerging CNS-directed precision therapies
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1717432
- 1,202 views
Original Research
Published on 21 Jan 2026
The modified Glasgow prognostic score serves as a robust predictor of unplanned readmission and 1-year mortality in lung cancer patients receiving immune checkpoint inhibitors
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1698848
- 693 views